Clinical trial
Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl…
NCT00118612 · Allergy Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00118612 |
|---|---|
| Title | Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen |
| Official title | A DoubleBlind Phase 2b Study to Evaluate Safety & Efficacy of Different Doses of Tyrosine Adsorbed Birch+Hazel+Alder Pollen Allergoid With MPL® in Patients Sensitized to Birch, Hazel, Alder Pollen |
| Lead sponsor | Allergy Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type I Hypersensitivity |
| Intervention type | Biological |
| Interventions | Tree MATA MPL - Therapeutic Regimen, Tree MATA MPL - Intermediate dose, Tree MATA MPL - Low dose, Placebo |
| Enrollment | 68 |
| Start date | Jul 7, 2005 |
| Primary completion | Sep 15, 2005 |
| Completion | Sep 15, 2005 |
| First posted | Jul 12, 2005 |
| Last update posted | Feb 9, 2021 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: